跳至主要内容
临床试验/NCT04812873
NCT04812873已完成不适用

The Prevalence of ID (Iron Deficiency) & IDA (Iron Deficiency Anemia) in Korean Patients With Heart Failure

JW Pharmaceutical1 个研究点 分布在 1 个国家目标入组 465 人开始时间: 2019年1月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
465
试验地点
1
主要终点
The Prevalence of Iron Deficiency

研究概览

简要总结

The prevalence of Iron Deficiency and Iron Deficiency Anemia in Korean HF patient

详细描述

Epidemiological study to assess The prevalence of ID (Iron Deficiency) & IDA (Iron Deficiency Anemia) in Korean patients with heart failure

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • more than 19 years old
  • Informed Consent Form
  • Hear Failure criteria as belows
  • Heart Failure Sign(more than 1 Sx such as fatigue, dyspnea, ankle swelling)
  • Heart Failure Symptom(more than 1 among Jugular venous pressure (JVP) elevation, pulmonary crackle, peripheral edema) ③ Lung congestion or edema at chest X-ray ④ Objective findings of structural or functional cardiac abnormality(more than abnormality level of BNP or NT-proBNP, abnormality of echocardiography )

排除标准

  • Not applicable

结局指标

主要结局

The Prevalence of Iron Deficiency

时间窗: 1 day

serum ferritin \< 100 ㎍/L or serum ferritin 100-299 ㎍/L and TSAT\* \< 20%

The Prevalence of Iron Deficiency Anemia

时间窗: 1 day

include Iron Deficiency criteria \& Male: Hb \< 13 g/dL, Female Hb \< 12 g/dL

次要结局

  • Current Anemia treatment(1 day)

研究者

发起方
JW Pharmaceutical
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验